Bristol-Myers Squibb Company PFD CONV 2 inobhadhara rini?Bristol-Myers Squibb Company PFD CONV 2 inobhadhara chikamu kune gore negore, kubhadhara kwekupedzisira kwezvikamu paBMYMP zvigaro kwaiva 03/02/2020. Shanduro ipi iyo Bristol-Myers Squibb Company PFD CONV 2 inobhadhara?Iyo kambani Bristol-Myers Squibb Company PFD CONV 2 yakabhadhara 0.5 $ chikamu chimwe nechimwe nguva yekupedzisira uye mugove wekugoverwa kwegore negore waiva 0.044 %. Ndeipi chikamu chinotevera chekubhadhara zuva Bristol-Myers Squibb Company PFD CONV 2?Chikamu chinotevera chekugoverwa kwezvikamu zveBristol-Myers Squibb Company PFD CONV 2 inotarisirwa musi Kukadzi 2025. Mabhindauko ndeimwe yezvikamu zvakakosha zvemari inowanikwa kubva kuna varidzi. Ukuru uye zuva rekutorwa kwemigove zvinogadzwa nevatungamiriri vekambani. Bristol-Myers Squibb Company PFD CONV 2 nhoroondo yekubhadhara nhoroondo inowanikwa mune yedu online service. Nhoroondo yekugovera ye Bristol-Myers Squibb Company PFD CONV 2 inowanikwa kwenguva pfupi iri muchimiro chechita uye kwenguva yakareba iri muchimiro chetafura. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Zvigadziriswa Bristol-Myers Squibb Company PFD CONV 2 mushure mekubhadharaYakakura iyo mari yekubhadhara, yakakwira bharati yetaiti. Zviri nyore zvakakwana kuti utarise masimba ehuwandu hwemigove yakagashirwa, uchiongorora kukwirira kwemakoramu echati. Misiyano Bristol-Myers Squibb Company PFD CONV 2, purogiramu yekubhadhara pamhepo inoratidzwa mumushandi wedu. Bristol-Myers Squibb Company PFD CONV 2 chikamu chekubhadhara chikamu chakapihwa kwemakore matatu apfuura. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Chikamu chekubhadhara chikamu Bristol-Myers Squibb Company PFD CONV 2Ruzivo pazuva richagoverwa pane BMYMP kugovaniswa kunopfupikiswa patafura yekushandira saiti yedu. Mutsara wega wega weyedhisheni yekubhadhara tafura inoenderana nezuva rayo rekubhadhara. Zuva razvino rekubhadhara zuva rekubhadhara Bristol-Myers Squibb Company PFD CONV 2 iri pamzere wekutanga petafura. Iwe unogona kuona saizi yemigove ye Bristol-Myers Squibb Company PFD CONV 2 yezuva rinodikanwa mukoramu yechipiri yetafura yekudyidzana. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Kuwanda kwemabhadharo ekugovera kune Bristol-Myers Squibb Company PFD CONV 2 patafura inoratidzwa chikamu chimwe nechimwe. Bristol-Myers Squibb Company PFD CONV 2 kugovera kubhadhara pane imwe chikamu kunoratidzwa mumadhora. Kugovera goho Bristol-Myers Squibb Company PFD CONV 2 ndiyo huwandu hwehuwandu hwemari inopihwa pagore pagore kune kukosha kwechikamu chimwe. Iyo yekugovera goho pa Bristol-Myers Squibb Company PFD CONV 2 shares i 0.044 % nhasi. Kugovera goho chiratidzo chakakosha kumutengesi pamwe chete neshanduko mukukosha kwemutengo we stock. Kugovera kwekugovera kwe Bristol-Myers Squibb Company PFD CONV 2 gore rakapfuura uye nhoroondo yekugovera gohwo kune mamwe makore makore mashoma apfuura ruzivo rwakakosha rwekuongorora hunhu hwekudyara mumigove yekambani ino. Nhoroondo yekugovera kukohwa kune makumi maviri apfuura ekubhadhara kunoratidzwa mu Bristol-Myers Squibb Company PFD CONV 2 dividend tafura yemafuta. Iyo yazvino dividend goho re Bristol-Myers Squibb Company PFD CONV 2 inogona kuoneka mumutsara wepamusoro petafura. |
Mari yezvikamu Bristol-Myers Squibb Company PFD CONV 2 |
||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
Mari Bristol-Myers Squibb Company PFD CONV 2 |
||||||||||||||||||||||||||||||||||||||
|
|
|